Sophoricoside

Sophoricoside
Product Name Sophoricoside
CAS No.: 152-95-4
Catalog No.: CFN90148
Molecular Formula: C21H20O10
Molecular Weight: 432.38 g/mol
Purity: >=98%
Type of Compound: Flavonoids
Physical Desc.: Powder
Targets: NF-kB | Caspase | MMP(e.g.TIMP) | Estrogen receptor | COX | IL Receptor | TNF-α | Progestogen receptor
Source: The fruits of Sophora japonica L.
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price: $40/20mg
Sophoricoside has anti-inflammatory, anti-cancer, anti-bone loss, and immunosuppressive effects. Sophoricoside is an effective regulator of lipogenesis and glucose consumption and may find utility in the treatment of obesity and type 2 diabetes. Sophoricoside exposure reduced the number of implanted embryos in a dose-dependent manner and failed the embryo implantation through altering the morphology of uterine and compromising the endometrial receptivity.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Molecules.2019, 24(7):E1290
  • Med Sci Monit.2019, 25:9499-9508
  • Korean Herb. Med. Inf. 2016, 4(1):35-42
  • J Chromatogr A.2017, 1518:46-58
  • Food Analytical Methods2020, 1-10
  • J Hematol Oncol.2018, 11(1):112
  • Psychopharmacology (Berl).2020, 10.1007
  • Int Immunopharmacol.2019, 71:22-31
  • J of Ana. Chem.2019, 74(11):1113-1121
  • J Biochem Mol Toxicol.2017, 31(9)
  • Daidzin

    Catalog No: CFN99101
    CAS No: 552-66-9
    Price: $40/20mg
    Daidzein 7-O-glucuronide

    Catalog No: CFN70352
    CAS No: 38482-80-3
    Price: Inquiry(manager@chemfaces.com)
    Dihydrodaidzin

    Catalog No: CFN90755
    CAS No: 121927-96-6
    Price: Inquiry(manager@chemfaces.com)
    4''-methyloxy-Daidzin

    Catalog No: CFN93005
    CAS No: 1195968-02-5
    Price: Inquiry(manager@chemfaces.com)
    Daidzin 6''-O-malonate

    Catalog No: CFN91028
    CAS No: 124590-31-4
    Price: $413/5mg
    8-O-Methylretusin-7-O-beta-D-glucopyranoside

    Catalog No: CFN92917
    CAS No: 68862-13-5
    Price: Inquiry(manager@chemfaces.com)
    Ononin

    Catalog No: CFN99136
    CAS No: 486-62-4
    Price: $148/20mg
    Daidzein-4',7-diglucoside

    Catalog No: CFN95094
    CAS No: 53681-67-7
    Price: $288/10mg
    Calycosin-7-O-beta-D-glucoside

    Catalog No: CFN99141
    CAS No: 20633-67-4
    Price: $128/20mg
    3'-Methoxydaidzin

    Catalog No: CFN89443
    CAS No: 200127-80-6
    Price: $218/10mg
    Molecules. 2013 Dec 13;18(12):15624-35.
    Modulation of lipogenesis and glucose consumption in HepG2 cells and C2C12 myotubes by sophoricoside.[Pubmed: 24352018]
    Sophoricoside, an isoflavone glycoside isolated from Sophora japonica (Leguminosae), has been widely reported as an immunomodulator. In this study, the effects of Sophoricoside on lipogenesis and glucose consumption in HepG2 cells and C2C12 myotubes were investigated.
    METHODS AND RESULTS:
    Treatment with Sophoricoside at concentrations of 1-10 μM inhibited lipid accumulation in HepG2 cells in a dose-dependent manner. At the same concentration range, no effect on cell viability was observed in the MTT assay. Inhibition of lipogenesis was associated with the downregulation of SREBP-1a, SREBP-1c, SREBP-2 and their downstream target genes (FAS, ACC, HMGR) as revealed by realtime quantitative PCR. The lipid-lowering effect was mediated via the phosphorylation of AMPK. Further investigation of the activities of this isoflavone showed that Sophoricoside has the capability to increase glucose uptake by C2C12 myotubes. It also effectively inhibited the activities of α-glucosidase and α-amylase in vitro and remarkably lowered postprandial hyperglycaemia in starch-loaded C57BL6/J mice.
    CONCLUSIONS:
    These results suggest that Sophoricoside is an effective regulator of lipogenesis and glucose consumption and may find utility in the treatment of obesity and type 2 diabetes.
    World J Microbiol Biotechnol. 2015 Jan;31(1):187-97.
    Effective bioconversion of sophoricoside to genistein from Fructus sophorae using immobilized Aspergillus niger and Yeast.[Pubmed: 25392205]
    In this study, Sophoricoside from Fructus sophorae was highly bioconversed to genistein by co-immobilized Aspergillus niger and Yeast.
    METHODS AND RESULTS:
    Bioconversion conditions for genistein were optimized with single-factor experiments. The optimal conditions were as follows: microbial concentration 1.5 × 10(7) cells/mL, wet weight of microorganisms beads 10.0 g/g material, pH 5, ratio of liquid to solid 25:1 (mL/g), temperature 32 °C and time 24 h. Under these conditions, a 34.45-fold increase in production of genistein was observed with a bioreactor. Moreover, the antioxidant activities of the extracts from the fermented and untreated F. sophorae were 0.287 ± 0.11, 0.384 ± 0.08 mg/mL (IC50) and 1.84 ± 0.13, 1.28 ± 0.25 mmol Fe(II)/g, according to the DPPH test and FRAP assay, respectively.
    CONCLUSIONS:
    The results indicated that the method described in the current work were valuable procedure for the production of genistein, which is of most importance for industrial scale applications as well as food industry.
    Chem Biol Interact. 2014 Aug 5;219:57-63.
    Sophoricoside fails the embryo implantation by compromising the uterine endometrial receptivity at implantation [Pubmed: 24877640 ]
    Sophoricoside (SOPH) is an isoflavone glycoside isolated from the fruits of Sophora japonica. Since its first isolation in 1961, there are rare findings about the effects of SOPH on reproductive system.
    METHODS AND RESULTS:
    In the present study, the pregnant mice administrated by different doses of SOPH were used to explore the effect of SOPH on embryo implantation, especially on the endometrial receptivity. The statistical results showed that the number of implanted embryos was gradually declining along the increasing dose of SOPH. When the administrated dose of SOPH was 600 mg/kg per day, great changes were observed in the exposed uterine morphology and up-regulated progesterone receptor (PR) and down-regulated estrogen receptor α (ERα), E-cadherin, matrix metalloproteinase-2 (MMP-2) and integrin β3 were also found in SOPH-exposed uterine.
    CONCLUSIONS:
    These findings demonstrated that SOPH exposure reduced the number of implanted embryos in a dose-dependent manner and failed the embryo implantation through altering the morphology of uterine and compromising the endometrial receptivity.
    Arch Pharm Res. 2003 Apr;26(4):306-11.
    Anti-inflammatory mode of isoflavone glycoside sophoricoside by inhibition of interleukin-6 and cyclooxygenase-2 in inflammatory response.[Pubmed: 12735689]
    Soy, high dietary intake for the oriental population, is a main source of isoflavonoids. Sophoricoside (SOP) an isoflavone glycoside was isolated from immature fruits of Sophora japonica (Leguminosae family) and its inhibitory effect on chemical mediators involved in inflammatory response was investigated in this study.
    METHODS AND RESULTS:
    SOP inhibited the interleukin (IL)-6 bioactivity with an IC50 value of 6.1 microM whereas it had no effects on IL-1beta and TNF-alpha bioactivities. SOP was identified as a selective inhibitor of cyclooxygenase (COX)-2 activity with an IC50 value of 4.4 microM, but did not show inhibitory effect on the synthesis of COX-2. However, SOP had no effect on the production of reactive oxygen species including superoxide anions and nitric oxide. These results revealed that in vitro anti-inflammatory action of SOP is significantly different from that of genistein known as a phytoestrogen of soy products.
    CONCLUSIONS:
    This experimental study has documented an importance of dietary soy isoflavonoids as multifunctional agents beneficial to human health, and will help to clarify protective mechanisms of SOP against inflammatory conditions.
    Molecules. 2013 May 22;18(5):6113-27.
    The ameliorative effect of sophoricoside on mast cell-mediated allergic inflammation in vivo and in vitro.[Pubmed: 23698058]
    Sophoricoside exhibits numerous pharmacological effects, including anti- inflammatory and anti-cancer actions, yet the exact mechanism that accounts for the anti-allergic effects of Sophoricoside is not completely understood. The aim of the present study was to elucidate whether and how Sophoricoside modulates the mast cell-mediated allergic inflammation in vitro and in vivo.
    METHODS AND RESULTS:
    We investigated the pharmacological effects of Sophoricoside on both compound 48/80 or histamine-induced scratching behaviors and 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis in mice. Additionally, to find a possible explanation for the anti-inflammatory effects of Sophoricoside, we evaluated the effects of Sophoricoside on the production of histamine and inflammatory cytokines and activation of nuclear factor-κB (NF-κB) and caspase-1 in phorbol 12-myristate 13-acetate plus calcium ionophore A23187 (PMACI)-stimulated human mast cells (HMC-1). The finding of this study demonstrated that Sophoricoside reduced compound 48/80 or histamine-induced scratching behaviors and DNCB-induced atopic dermatitis in mice. Additionally, Sophoricoside inhibited the production of inflammatory cytokines as well as the activation of NF-κB and caspase-1 in stimulated HMC-1.
    CONCLUSIONS:
    Collectively, the findings of this study provide us with novel insights into the pharmacological actions of Sophoricoside as a potential molecule for use in the treatment of allergic inflammation diseases.
    Zhong Xi Yi Jie He Xue Bao. 2003 May;1(1):44-6.
    Effect of Sophoricoside on histomorphology of bone in ovariectomized rats.[Pubmed: 15339615]
    To evaluate the potential preventive effect of Sophoricoside on bone loss in ovariectomized rats.
    METHODS AND RESULTS:
    Female SD rats (n=50, 6 months old) were either sham-operated (SHAM group, n=10) or ovariectomized (n=40). Three days after operation, ovariectomized rats were randomly assigned to groups as follows: 10 received Sophoricoside 4 mg.kg(-1).d(-1) (SL group), 10 received Sophoricoside 8 mg.kg(-1).d(-1) (SM group), 10 received Sophoricoside 16 mg.kg(-1).d(-1) (SH group) and 10 were untreated (OVX group). After Sophoricoside were given orally for one month, the histomorphometric parameters in the secondary spongiosa of proximal tibia and lumbar vertebrae were examined. Compared with OVX group, SM and SH two kinds of treatment caused 15.28% and 22.81% increment in percent trabecular area (BV/TV, %) in the secondary spongiosa of proximal tibia, 14.23% and 21.2% increment in lumbar vertebrae. Accordingly in these two groups, there was a significant decrease in trabecular separation (FLAW, microm), but increment in trabecular width (Tb. Th, microm) and conjunction points (JOINT). But in SL group, the preventive effect was not observed.
    CONCLUSIONS:
    Sophoricoside can be efficient in preventing ovariectomy-induced bone loss in rats.
    Syringaresinol-di-O-glucoside

    Catalog No: CFN90458
    CAS No: 66791-77-3
    Price: $218/20mg
    11-Hydroxycanthin-6-one

    Catalog No: CFN92125
    CAS No: 75969-83-4
    Price: $413/5mg
    Licoricone

    Catalog No: CFN96504
    CAS No: 51847-92-8
    Price: $333/5mg
    Epiaschantin

    Catalog No: CFN96901
    CAS No: 41689-50-3
    Price: $368/5mg
    Angelol M

    Catalog No: CFN95060
    CAS No: 1092952-64-1
    Price: $288/5mg
    Selina-4(15),7(11)-dien-8-one

    Catalog No: CFN95078
    CAS No: 54707-47-0
    Price: $288/10mg
    (Z)-Aldosecologanin (Centauroside)

    Catalog No: CFN95079
    CAS No: 82474-97-3
    Price: $388/5mg
    Caraganaphenol A

    Catalog No: CFN95093
    CAS No: 174916-31-5
    Price: $333/5mg
    Polygalasaponin XXXV

    Catalog No: CFN95176
    CAS No: 184479-28-5
    Price: $463/5mg
    Pueroside A

    Catalog No: CFN95177
    CAS No: 100692-52-2
    Price: $318/5mg